Table 2.
Diseases that can exploit the human microbiome and microbiota metabolites as diagnostic biomarkers.
Disease | Evidence of Microbiome Involvement |
---|---|
Acne | [169,170,171,172] |
Allergic Rhinitis | [173,174] |
Alzheimer’s Disease | [175,176,177,178] |
Amyotrophic Lateral Sclerosis | [179,180,181] |
Ankylosing Spondylitis | [182,183] |
Anxiety Disorders | [184,185,186] |
Asthma | [187,188,189] |
Atopic Dermatitis | [190,191,192] |
Autism Spectrum Disorders | [193,194,195,196] |
Behcet’s Disease | [197,198,199] |
Breast Cancer | [200,201] |
Cardiovascular Disease | [202,203] |
Chronic Constipation | [204,205] |
Coronaviruses | [206,207,208] |
Depression | [209,210] |
Diabetes | [211,212] |
Diarrheal Diseases | [213,214,215] |
Epilepsy | [216,217] |
Fibromyalgia Syndrome | [218,219] |
Fungal Infections | [220] |
Headache Disorders | [221] |
HIV and AIDS | [222,223] |
Inflammatory Bowel Disease (Crohn’s Disease and Ulcerative Colitis) | [224,225] |
Irritable Bowel Syndrome | [226,227] |
Lung Cancer | [228,229] |
Melanoma | [230,231] |
Metabolic Syndrome | [232,233] |
Multidrug-Resistant Bacterial Infections | [234,235] |
Multiple Sclerosis | [236,237] |
Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | [238,239] |
Neurologic Cancer | [240,241] |
Nonalcoholic Fatty Liver Disease | [242,243] |
Obesity | [244,245] |
Pain | [246,247] |
Pancreatic Cancer | [248,249] |
Parkinson’s Disease | [250,251] |
Phenylketonuria | [252,253] |
Psoriasis | [254,255] |
Rheumatoid Arthritis | [256,257] |
Rosacea | [258,259] |
Transplant Rejection | [260,261] |
Tuberculosis | [262,263] |
Wound Healing | [264,265] |